Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue

Njira Lugogo,1 Ileen Gilbert,2 Michael Pollack,2 Hitesh Gandhi,2 Joseph Tkacz,3 Miguel J Lanz4 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA; 2BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA; 3Inovalon, Bowie, MD, U...

Full description

Bibliographic Details
Main Authors: Lugogo N, Gilbert I, Pollack M, Gandhi H, Tkacz J, Lanz MJ
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:Journal of Asthma and Allergy
Subjects:
Online Access:https://www.dovepress.com/estimating-inhaled-corticosteroid-exposure-from-short-acting-2-agonist-peer-reviewed-fulltext-article-JAA
Description
Summary:Njira Lugogo,1 Ileen Gilbert,2 Michael Pollack,2 Hitesh Gandhi,2 Joseph Tkacz,3 Miguel J Lanz4 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA; 2BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA; 3Inovalon, Bowie, MD, USA; 4Allergy and Asthma, AAADRS Clinical Research Center, Coral Gables, FL, USACorrespondence: Michael Pollack, BioPharmaceuticals Medical, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA, Tel +1-302-886-1253, Email Michael.pollack1@astrazeneca.com
ISSN:1178-6965